Productionizing synthetic biology: The Digest’s 2017 Multi-Slide Guide to the Agile BioFoundry

The Agile BioFoundry, designed to productionize synthetic biology, is a public infrastructure investment aimed at increasing U.S. industrial competitiveness and enables new opportunities for private sector growth and jobs. Specifically, the foundry aims to enable a biorefineryto achieve a positive return on investment through a 50% reduction in time-to-scale up compared to the average of ~10 years.

A 10X improvement in Design-Build-Test-Learn cycle efficiency, new host organisms, new IP and manufacturing technologies effectively translated to U.S. industry ensuring market transformation — that’s in the cards with this project.

Nathan J. Hillson of Lawrence Berkeley National Lab gave this illuminating presentation on the Agile BioFoundry’s promise and progress at the DOE Project Peer Review meetings.